SCHEMBL7239236

SCHEMBL7239236

C=CCOC(=O)N1C[C@@H](SC(=O)OC(C)(C)C)C[C@H]1CO

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.35
SRC P12931 8/20 0.31
CYP19A1 P11511 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9132239 1.00 NR1H2 (0.35) NR1H2SRCCYP19A1SIGMAR1SMN1; SMN2
SCHEMBL9132721 0.90 CYP19A1 (0.31) CYP19A1SIGMAR1
SCHEMBL7805577 0.85 ECE1 (0.33) CYP19A1SIGMAR1
SCHEMBL7233657 0.85 SIGMAR1 (0.33) NR1H2CYP19A1SIGMAR1SMN1; SMN2
SCHEMBL9132237 0.82 CYP19A1 (0.42) NR1H2CYP19A1SMN1; SMN2
SCHEMBL9132827 0.80 NPSR1 (0.43) CYP19A1SIGMAR1
SCHEMBL15275774 0.78 BTK (0.39) NR1H2CYP19A1SMN1; SMN2
SCHEMBL13554888 0.78 BTK (0.39) NR1H2CYP19A1SMN1; SMN2
SCHEMBL7235416 0.77 CYP19A1 (0.38) CYP19A1
SCHEMBL8550129 0.76 CYP19A1 (0.35) CYP19A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6541491-B1 Treating ras mediated diseases, especially cancer. ZENECA LIMITED (GB) 2003-04-01 US disclosed
US-6232338-B1 4-Mercaptopyrrolidine derivatives as farnesyl transferase inhibitors ZENECA LIMITED (GB) 2001-05-15 US disclosed
EP-0842151-A1 4-MERCAPTOPYRROLIDINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS ZENECA LIMITED (GB) 1998-05-20 EP disclosed
WO-1997006138-A1 4-MERCAPTOPYRROLIDINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS ZENECA LIMITED (GB) 1997-02-20 WO disclosed